CVS Unit Must Pay Nearly $290 Million in Medicare Whistleblower Lawsuit, Judge Rules

The fraud committed by Caremark was financially motivated and not due to some ‘innocent or mistaken belief,’ the judge wrote.

A customer leaves a CVS Pharmacy in Irvine, Calif., on Feb. 11, 2021. John Fredricks/The Epoch Times

A federal judge has ordered CVS Caremark Corp., a pharmacy benefit manager (PBM), to pay nearly $290 million in damages and penalties after it overcharged Medicare for prescription drugs.

In an Aug. 19 decision, Judge Mitchell S. Goldberg of the Eastern District of Pennsylvania tripled to $285 million the original damages he ordered CVS Caremark to pay in June, citing the federal False Claims Act. He also added a $4.87 million civil fine.